NewAmsterdam Pharma (NASDAQ:NAMSW) Trading Up 8.9% – What’s Next?

Shares of NewAmsterdam Pharma (NASDAQ:NAMSW) were up 8.9% during mid-day trading on Friday . The company traded as high as $18.80 and last traded at $19.5930. Approximately 279 shares traded hands during trading, a decline of 84% from the average daily volume of 1,760 shares. The stock had previously closed at $17.99.

NewAmsterdam Pharma Stock Performance

The business has a 50 day moving average price of $22.76 and a 200-day moving average price of $22.86.

Institutional Investors Weigh In On NewAmsterdam Pharma

A hedge fund recently bought a new stake in NewAmsterdam Pharma stock. Aristeia Capital L.L.C. bought a new stake in shares of NewAmsterdam Pharma (NASDAQ:NAMSW) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 15,708 shares of the company’s stock, valued at approximately $397,000.

About NewAmsterdam Pharma

NewAmsterdam Pharma, Inc is a clinical-stage biotechnology company focused on the development of orally delivered peptide therapeutics for the treatment of metabolic diseases. Drawing upon proprietary peptide chemistry and formulation technologies, the company aims to transform injectable treatments for conditions such as type 2 diabetes, obesity and related cardiometabolic disorders into convenient, once-daily oral medications. By harnessing advances in peptide stabilization and targeted delivery, NewAmsterdam Pharma seeks to improve patient adherence and expand access to novel therapies.

The company’s lead program is an oral glucagon‐like peptide‐1 (GLP-1) receptor agonist currently in early clinical trials.